Skip to main content
. 2020 Jul 29;61(8):44. doi: 10.1167/iovs.61.8.44

Figure 4.

Figure 4.

AH6809 suppresses scleral cAMP increases during FD. Myopic scleral cAMP increases were inhibited by AH6809 injections during FD. AH6809 did not significantly affect cAMP levels during normal ocular growth. Mean cAMP data presented as femtomole/milligram of the tissue (± SD). *P < 0.05; **P < 0.01; one-way ANOVA with Bonferroni correction.